vs

Side-by-side financial comparison of Grindr Inc. (GRND) and RIGEL PHARMACEUTICALS INC (RIGL). Click either name above to swap in a different company.

Grindr Inc. is the larger business by last-quarter revenue ($126.0M vs $69.8M, roughly 1.8× RIGEL PHARMACEUTICALS INC). RIGEL PHARMACEUTICALS INC runs the higher net margin — 384.0% vs 16.1%, a 368.0% gap on every dollar of revenue. On growth, Grindr Inc. posted the faster year-over-year revenue change (29.0% vs 21.2%). Over the past eight quarters, RIGEL PHARMACEUTICALS INC's revenue compounded faster (53.7% CAGR vs 29.3%).

Grindr is a location-based social networking and online hookup application for LGBTQ people.

Rigel Pharmaceuticals Inc is a clinical-stage biotechnology company focused on developing and commercializing targeted small molecule therapies for autoimmune, inflammatory, and hematologic diseases. Its approved flagship product treats adult immune thrombocytopenia, with primary operations and core markets in the United States, addressing unmet medical needs for underserved patient groups.

GRND vs RIGL — Head-to-Head

Bigger by revenue
GRND
GRND
1.8× larger
GRND
$126.0M
$69.8M
RIGL
Growing faster (revenue YoY)
GRND
GRND
+7.9% gap
GRND
29.0%
21.2%
RIGL
Higher net margin
RIGL
RIGL
368.0% more per $
RIGL
384.0%
16.1%
GRND
Faster 2-yr revenue CAGR
RIGL
RIGL
Annualised
RIGL
53.7%
29.3%
GRND

Income Statement — Q4 FY2025 vs Q4 FY2025

Metric
GRND
GRND
RIGL
RIGL
Revenue
$126.0M
$69.8M
Net Profit
$20.3M
$268.1M
Gross Margin
91.5%
Operating Margin
24.9%
33.2%
Net Margin
16.1%
384.0%
Revenue YoY
29.0%
21.2%
Net Profit YoY
116.4%
1769.2%
EPS (diluted)
$0.10
$14.11

Green = leading value per metric. Periods may differ when fiscal calendars don't align.

8-Quarter Revenue & Profit Trend

Side-by-side quarterly history. Quarters aligned by calendar period so offset fiscal years line up.

Revenue
GRND
GRND
RIGL
RIGL
Q4 25
$126.0M
$69.8M
Q3 25
$115.8M
$69.5M
Q2 25
$104.2M
$101.7M
Q1 25
$93.9M
$53.3M
Q4 24
$97.6M
$57.6M
Q3 24
$89.3M
$55.3M
Q2 24
$82.3M
$36.8M
Q1 24
$75.3M
$29.5M
Net Profit
GRND
GRND
RIGL
RIGL
Q4 25
$20.3M
$268.1M
Q3 25
$30.8M
$27.9M
Q2 25
$16.6M
$59.6M
Q1 25
$27.0M
$11.4M
Q4 24
$-123.9M
$14.3M
Q3 24
$24.7M
$12.4M
Q2 24
$-22.4M
$-1.0M
Q1 24
$-9.4M
$-8.2M
Gross Margin
GRND
GRND
RIGL
RIGL
Q4 25
91.5%
Q3 25
93.2%
Q2 25
95.6%
Q1 25
91.7%
Q4 24
89.9%
Q3 24
85.5%
Q2 24
92.4%
Q1 24
93.1%
Operating Margin
GRND
GRND
RIGL
RIGL
Q4 25
24.9%
33.2%
Q3 25
39.1%
40.9%
Q2 25
23.4%
60.1%
Q1 25
27.0%
23.9%
Q4 24
20.9%
28.9%
Q3 24
31.8%
25.4%
Q2 24
29.8%
1.2%
Q1 24
25.6%
-23.6%
Net Margin
GRND
GRND
RIGL
RIGL
Q4 25
16.1%
384.0%
Q3 25
26.6%
40.2%
Q2 25
16.0%
58.6%
Q1 25
28.8%
21.5%
Q4 24
-126.9%
24.9%
Q3 24
27.6%
22.5%
Q2 24
-27.2%
-2.8%
Q1 24
-12.5%
-27.9%
EPS (diluted)
GRND
GRND
RIGL
RIGL
Q4 25
$0.10
$14.11
Q3 25
$0.16
$1.46
Q2 25
$0.08
$3.28
Q1 25
$0.09
$0.63
Q4 24
$-0.65
$0.82
Q3 24
$0.09
$0.70
Q2 24
$-0.13
$-0.06
Q1 24
$-0.05
$-0.47

Balance Sheet & Financial Strength

Snapshot of each company's liquidity, leverage and book value from the latest quarter.

Metric
GRND
GRND
RIGL
RIGL
Cash + ST InvestmentsLiquidity on hand
$87.0M
$155.0M
Total DebtLower is stronger
$395.9M
$52.5M
Stockholders' EquityBook value
$47.0M
$391.5M
Total Assets
$531.0M
$513.6M
Debt / EquityLower = less leverage
8.42×
0.13×

8-quarter trend — quarters aligned by calendar period.

Cash + ST Investments
GRND
GRND
RIGL
RIGL
Q4 25
$87.0M
$155.0M
Q3 25
$6.3M
$137.1M
Q2 25
$120.8M
$108.4M
Q1 25
$255.9M
$77.1M
Q4 24
$59.2M
$77.3M
Q3 24
$39.1M
$61.1M
Q2 24
$16.3M
$49.1M
Q1 24
$21.5M
$49.5M
Total Debt
GRND
GRND
RIGL
RIGL
Q4 25
$395.9M
$52.5M
Q3 25
$279.9M
$60.0M
Q2 25
$283.5M
$60.0M
Q1 25
$287.0M
$60.0M
Q4 24
$290.6M
$60.0M
Q3 24
$294.1M
$60.0M
Q2 24
$297.7M
$60.0M
Q1 24
$315.0M
$60.0M
Stockholders' Equity
GRND
GRND
RIGL
RIGL
Q4 25
$47.0M
$391.5M
Q3 25
$71.0M
$117.6M
Q2 25
$187.7M
$81.9M
Q1 25
$319.8M
$18.6M
Q4 24
$-131.6M
$3.3M
Q3 24
$-13.4M
$-14.6M
Q2 24
$-41.7M
$-29.9M
Q1 24
$-22.0M
$-31.7M
Total Assets
GRND
GRND
RIGL
RIGL
Q4 25
$531.0M
$513.6M
Q3 25
$439.2M
$242.5M
Q2 25
$547.6M
$206.7M
Q1 25
$679.4M
$176.0M
Q4 24
$479.1M
$164.0M
Q3 24
$456.3M
$139.4M
Q2 24
$435.0M
$128.4M
Q1 24
$437.7M
$126.5M
Debt / Equity
GRND
GRND
RIGL
RIGL
Q4 25
8.42×
0.13×
Q3 25
3.94×
0.51×
Q2 25
1.51×
0.73×
Q1 25
0.90×
3.23×
Q4 24
18.25×
Q3 24
Q2 24
Q1 24

Cash Flow & Capital Efficiency

How much cash each business actually produces after reinvestment. Cash flow is harder to manipulate than net income.

Metric
GRND
GRND
RIGL
RIGL
Operating Cash FlowLast quarter
$24.8M
$22.0M
Free Cash FlowOCF − Capex
$24.5M
FCF MarginFCF / Revenue
19.5%
Capex IntensityCapex / Revenue
0.2%
Cash ConversionOCF / Net Profit
1.22×
0.08×
TTM Free Cash FlowTrailing 4 quarters
$140.8M

8-quarter trend — quarters aligned by calendar period.

Operating Cash Flow
GRND
GRND
RIGL
RIGL
Q4 25
$24.8M
$22.0M
Q3 25
$55.4M
$24.0M
Q2 25
$37.5M
$30.5M
Q1 25
$23.8M
$-893.0K
Q4 24
$29.5M
$14.5M
Q3 24
$29.1M
$21.7M
Q2 24
$15.8M
$302.0K
Q1 24
$20.4M
$-5.0M
Free Cash Flow
GRND
GRND
RIGL
RIGL
Q4 25
$24.5M
Q3 25
$55.2M
Q2 25
$37.3M
Q1 25
$23.7M
Q4 24
$29.3M
Q3 24
$28.8M
Q2 24
$15.7M
Q1 24
$20.3M
FCF Margin
GRND
GRND
RIGL
RIGL
Q4 25
19.5%
Q3 25
47.7%
Q2 25
35.8%
Q1 25
25.2%
Q4 24
30.0%
Q3 24
32.2%
Q2 24
19.0%
Q1 24
26.9%
Capex Intensity
GRND
GRND
RIGL
RIGL
Q4 25
0.2%
Q3 25
0.2%
Q2 25
0.2%
Q1 25
0.1%
Q4 24
0.3%
Q3 24
0.4%
Q2 24
0.2%
Q1 24
0.3%
Cash Conversion
GRND
GRND
RIGL
RIGL
Q4 25
1.22×
0.08×
Q3 25
1.80×
0.86×
Q2 25
2.25×
0.51×
Q1 25
0.88×
-0.08×
Q4 24
1.01×
Q3 24
1.18×
1.75×
Q2 24
Q1 24

Financial Flow Comparison

Revenue → gross profit → operating profit → net profit for each company.

Revenue Breakdown by Segment

GRND
GRND

License And Service$102.9M82%
Advertising$23.1M18%

RIGL
RIGL

Segment breakdown not available.

Related Comparisons